Predicting the Crash… PERT trainee council rep @docyams leading the panel discussion on one of our most challenging clinical dilemmas. Who will need to be rescued?
60
Was an honor to speak at #PERT2026 this year thank you Jeff Kline, @kavaliIR, Soophia Naydenov, Stephanie Younes, Cameron McGuire for the support and giving me the platform to speak on the case that started my passion for PE @PERTConsortium
Replying to @docyams
@docyams of the @PERTConsortium #TraineeCouncil discusses an excellent case focused on predicting clinical decompensation at #PERT2026
🔑 takeaways:
1️⃣ Syncope is a high risk feature
2️⃣ Risk stratification is not a single time event
3️⃣ Not all clot-in-transit is treated equally
1
105
Power panel!!! Such a huge fan of @AnnGageMD , Maya Serhal, Meno Huisman, Michael Young and Jeff Kline, loved thendiscusdion on intermediate risk PE. #PERT2026
1
67
Love the idea of using a DOAC Dashboard, fantastic talk by Geoffrey Barnes at #PERT2026
1
55
Dr. Elias Iliadis discusses and highlights treatment protocols for category E patients in our #HighRiskPE session #PERT2026
56
It was amazing to have @dandrews61 as our keynote speaker at #PERT2026
Dr. Ehret paving the way for trainees, she’s been a pillar of the PERT Trainee Council, so glad she’s one of our faculty members! #PERT2026 👏🏽👏🏽👏🏽
Dr. Jane Ehret, pulmonary and critical care fellow at University of Vermont, PERT Trainee Council graduate and faculty member, presenting an overview of advanced therapies for pulmonary embolism in pregnancy—a challenging clinical dilemma with a call to action to improve limited data. 🫁 #PERT2026 #PulmonaryEmbolism
89
“The guidelines don’t talk about clot burden, PERT teams talk about clot burdens” @rchannick reminding us the importance of PERTs for every PE patient! #PERT2026
Ann Gage had a fantastic answer to this question about use of LMWH in ECMO patients! Such a great session at #PERT2026
Is low molecular weight heparin a better drug than unfractionated heparin? Dr @rchannick peppering the panel and the question is hot!! #live at #PERT2026
70
If you’re interested in joining the #PERTTraineeCouncil, please apply next year! If you’re at #PERT2026 find one of us, we’d love to talk about it! Joining the @PERTConsortium has been the best part of my year
You paved the way for yourselves! So proud of the 💥 evolution of the @PERTConsortium #PERT2026 #PERTTrainee Council. Rockstars each and every one. The future of 🫁#PE🫀 is in great hands!
Tim Morris brought humor and a fantastic conversation on intelligence, both brain and artificial, to the AI debate at #PERT2026
35
#PERT2026 it’s fantastic to hear how quickly and large the PERT Consortium has grown with CoE and PRISM, 54 sites!!
Our president @DrMahirElder discussing the success of PERT with our past presidents @krosenfieldMD @rchannick @RosovskyRachel @roblookstein @vic_tapson
64
Discussing beyond the guidelines with such a powerful panel of international speakers at #PERT2026 . Are you pro enoxaparin?
60
Dr Beverly Hunt, our 2026 founder’s award recipient engaging with the panel at #PERT2026
43
A few additional tools for your PE POCUS assessment: RVOT waveform notching, acceleration time, and TAPSE/PASP. The “60/60 sign”—PA acceleration time <60 ms with a TR gradient <60 mmHg—can also support acute PE physiology and help refine risk stratification. #PERT2026
50
Dr. Gundert showing off some POCUS swag 👀 POCUS can add tremendously to PE assessment—refining pretest probability and risk stratification by identifying RV pressure/volume overload and RV–PA uncoupling.
#PERT2026
1
85
Functional Outcomes improved at 90 days in CAVT patients compared to AC alone. Exciting and novel patient-centered outcomes for C3 PE patients. #STORM-PE
46



























